No High Court Review For FDA Fast-Track Denial
By Gianna Ferrarin · November 17, 2025, 9:46 AM EST
The U.S. Supreme Court on Monday said it would not consider whether federal drug regulators went astray in denying fast-track review for a digestive disorder medication being developed by Vanda Pharmaceuticals....
To view the full article, register now.